Literature DB >> 29099606

Comparison of Nutrition and Lung Function Outcomes in Patients with Cystic Fibrosis Living in Canada and the United States.

Christopher H Goss1, Jenna Sykes2, Sanja Stanojevic3,4, Bruce Marshall5, Kristofer Petren5, Josh Ostrenga5, Aliza Fink5, Alexander Elbert5, Bradley S Quon6, Anne L Stephenson2,4,7.   

Abstract

RATIONALE: A 10-year gap in the median age of survival for patients with cystic fibrosis (CF) was reported between patients living in Canada compared with patients living in the United States.
OBJECTIVES: Because both malnutrition and poor lung function are associated with an increased risk of mortality in CF, we investigated the temporal and longitudinal trends in lung function and nutrition between Canada and the United States.
METHODS: This cohort study used Canadian CF Registry and U.S. CF Foundation Patient Registry data from 1990 to 2013. A unified dataset was created to harmonize the variables collected within the two registries for the purpose of comparing outcomes between the two countries.
MEASUREMENTS AND MAIN RESULTS: We conducted three analyses: survival differences by birth cohort; population trends for FEV1 and body mass index (BMI) over time; and individual patient FEV1 and BMI trajectories. The study included a total of 37,772 patients in the United States and 5,149 patients in Canada. Patients with CF experienced significant improvements in nutritional status and lung function in both Canada and the United States during the study. In addition, the survival gap between the two countries is narrowing within younger birth cohorts. The improvements for the patients within the United States were most prominent in the BMI trajectories, where patients born after 1990 in the United States have higher BMI that has persisted over time.
CONCLUSIONS: The reasons for the observed improvements, and catch-up in the United States, are likely multifactorial and include the introduction of high-fat, high-calorie diets; introduction of newborn screening; and/or improved access to care for CF children in the United States.

Entities:  

Keywords:  cystic fibrosis; international comparison; lung function; nutrition; survival

Mesh:

Year:  2018        PMID: 29099606      PMCID: PMC5855073          DOI: 10.1164/rccm.201707-1541OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   30.528


  22 in total

1.  The ongoing tyranny of statistical significance testing in biomedical research.

Authors:  Andreas Stang; Charles Poole; Oliver Kuss
Journal:  Eur J Epidemiol       Date:  2010-03-26       Impact factor: 8.082

2.  Cystic Fibrosis Diagnostic Challenges over 4 Decades: Historical Perspectives and Lessons Learned.

Authors:  Philip M Farrell; Terry B White; Nico Derichs; Carlo Castellani; Beryl J Rosenstein
Journal:  J Pediatr       Date:  2017-02       Impact factor: 4.406

Review 3.  Accelerating implementation of biomedical research advances: critical elements of a successful 10 year Cystic Fibrosis Foundation healthcare delivery improvement initiative.

Authors:  Bruce C Marshall; Eugene C Nelson
Journal:  BMJ Qual Saf       Date:  2014-04       Impact factor: 7.035

Review 4.  Key findings of the US Cystic Fibrosis Foundation's clinical practice benchmarking project.

Authors:  Michael P Boyle; Kathryn A Sabadosa; Hebe B Quinton; Bruce C Marshall; Michael S Schechter
Journal:  BMJ Qual Saf       Date:  2014-04       Impact factor: 7.035

5.  Outcomes of infants with indeterminate diagnosis detected by cystic fibrosis newborn screening.

Authors:  Clement L Ren; Aliza K Fink; Kristofer Petren; Drucy S Borowitz; Susanna A McColley; Don B Sanders; Margaret Rosenfeld; Bruce C Marshall
Journal:  Pediatrics       Date:  2015-05-11       Impact factor: 7.124

6.  A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis.

Authors:  Mark R Elkins; Michael Robinson; Barbara R Rose; Colin Harbour; Carmel P Moriarty; Guy B Marks; Elena G Belousova; Wei Xuan; Peter T P Bye
Journal:  N Engl J Med       Date:  2006-01-19       Impact factor: 91.245

7.  Improved asthma care after enrollment in the State Children's Health Insurance Program in New York.

Authors:  Peter G Szilagyi; Andrew W Dick; Jonathan D Klein; Laura P Shone; Jack Zwanziger; Alina Bajorska; H Lorrie Yoos
Journal:  Pediatrics       Date:  2006-02       Impact factor: 7.124

8.  CDC growth charts: United States.

Authors:  R J Kuczmarski; C L Ogden; L M Grummer-Strawn; K M Flegal; S S Guo; R Wei; Z Mei; L R Curtin; A F Roche; C L Johnson
Journal:  Adv Data       Date:  2000-06-08

9.  Survival Comparison of Patients With Cystic Fibrosis in Canada and the United States: A Population-Based Cohort Study.

Authors:  Anne L Stephenson; Jenna Sykes; Sanja Stanojevic; Bradley S Quon; Bruce C Marshall; Kristofer Petren; Josh Ostrenga; Aliza K Fink; Alexander Elbert; Christopher H Goss
Journal:  Ann Intern Med       Date:  2017-03-14       Impact factor: 25.391

10.  Joint modelling of repeated measurements and time-to-event outcomes: flexible model specification and exact likelihood inference.

Authors:  Jessica Barrett; Peter Diggle; Robin Henderson; David Taylor-Robinson
Journal:  J R Stat Soc Series B Stat Methodol       Date:  2014-04-08       Impact factor: 4.488

View more
  14 in total

Review 1.  Update in Cystic Fibrosis 2018.

Authors:  Bonnie W Ramsey; Gregory P Downey; Christopher H Goss
Journal:  Am J Respir Crit Care Med       Date:  2019-05-15       Impact factor: 21.405

2.  Improving lung transplant outcomes in France: the high emergency lung transplantation programme.

Authors:  Omar F Bayomy; Kathleen J Ramos; Christopher H Goss
Journal:  Eur Respir J       Date:  2022-01-27       Impact factor: 16.671

Review 3.  [Evidence-based treatment of cystic fibrosis].

Authors:  F C Ringshausen; T Hellmuth; A-M Dittrich
Journal:  Internist (Berl)       Date:  2020-12       Impact factor: 0.743

Review 4.  CFTR modulator theratyping: Current status, gaps and future directions.

Authors:  John Paul Clancy; Calvin U Cotton; Scott H Donaldson; George M Solomon; Donald R VanDevanter; Michael P Boyle; Martina Gentzsch; Jerry A Nick; Beate Illek; John C Wallenburg; Eric J Sorscher; Margarida D Amaral; Jeffrey M Beekman; Anjaparavanda P Naren; Robert J Bridges; Philip J Thomas; Garry Cutting; Steven Rowe; Anthony G Durmowicz; Martin Mense; Kris D Boeck; William Skach; Christopher Penland; Elizabeth Joseloff; Hermann Bihler; John Mahoney; Drucy Borowitz; Katherine L Tuggle
Journal:  J Cyst Fibros       Date:  2018-06-20       Impact factor: 5.482

Review 5.  The future of cystic fibrosis care: a global perspective.

Authors:  Scott C Bell; Marcus A Mall; Hector Gutierrez; Milan Macek; Susan Madge; Jane C Davies; Pierre-Régis Burgel; Elizabeth Tullis; Claudio Castaños; Carlo Castellani; Catherine A Byrnes; Fiona Cathcart; Sanjay H Chotirmall; Rebecca Cosgriff; Irmgard Eichler; Isabelle Fajac; Christopher H Goss; Pavel Drevinek; Philip M Farrell; Anna M Gravelle; Trudy Havermans; Nicole Mayer-Hamblett; Nataliya Kashirskaya; Eitan Kerem; Joseph L Mathew; Edward F McKone; Lutz Naehrlich; Samya Z Nasr; Gabriela R Oates; Ciaran O'Neill; Ulrike Pypops; Karen S Raraigh; Steven M Rowe; Kevin W Southern; Sheila Sivam; Anne L Stephenson; Marco Zampoli; Felix Ratjen
Journal:  Lancet Respir Med       Date:  2019-09-27       Impact factor: 30.700

6.  Body Mass Index Recovery after Lung Transplant for Cystic Fibrosis.

Authors:  Joseph B Pryor; Miranda C Bradford; Ann L Jennerich; Travis Y Hee Wai; Joseph M Pilewski; Siddhartha G Kapnadak; Moira L Aitken; Christopher H Goss; Kathleen J Ramos
Journal:  Ann Am Thorac Soc       Date:  2022-07

7.  Academy of Nutrition and Dietetics: 2020 Cystic Fibrosis Evidence Analysis Center Evidence-Based Nutrition Practice Guideline.

Authors:  Catherine M McDonald; Jessica A Alvarez; Julianna Bailey; Ellen K Bowser; Kristen Farnham; Mark Mangus; Laura Padula; Kathleen Porco; Mary Rozga
Journal:  J Acad Nutr Diet       Date:  2020-06-19       Impact factor: 5.234

Review 8.  Rapid therapeutic advances in CFTR modulator science.

Authors:  John P Clancy
Journal:  Pediatr Pulmonol       Date:  2018-11

9.  Clinical, genetic and microbiological characterization of pediatric patients with cystic fibrosis in a public Hospital in Ecuador.

Authors:  Yazmina Lascano-Vaca; Esteban Ortiz-Prado; Lenin Gomez-Barreno; Katherine Simbaña-Rivera; Eduardo Vasconez; Alexander Lister; María Emilia Arteaga-Espinosa; Geovanny F Perez
Journal:  BMC Pediatr       Date:  2020-03-06       Impact factor: 2.125

10.  Cystic fibrosis in South Africa: spectrum of disease and determinants of outcome.

Authors:  Marco Zampoli; Janine Verstraete; Marlize Frauendorf; Reshma Kassanjee; Lesley Workman; Brenda M Morrow; Heather J Zar
Journal:  ERJ Open Res       Date:  2021-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.